Related Experiment Video
Updated: May 10, 2026

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
RIG-I activation inhibits HIV replication in macrophages
Yizhong Wang1, Xu Wang, Jieliang Li
1Temple University School of Medicine, 843 MERB, 3500 N. Broad St., Philadelphia, PA 19140, USA. wenzheho@temple.edu
Abstract:
The RIG-I signaling pathway is critical in the activation of the type I IFN-dependent antiviral innate-immune response. We thus examined whether RIG-I activation can inhibit HIV replication in macrophages. We showed that the stimulation of monocyte-derived macrophages with 5'ppp-dsRNA, a synthetic ligand for RIG-I, induced the expression of RIG-I, IFN-α/β, and several IRFs, key regulators of the IFN signaling pathway. In addition, RIG-I activation induced the expression of multiple intracellular HIV-restriction factors, including ISGs, several members of the APOBEC3 family, tetherin and CC chemokines, the ligands for HIV entry coreceptor (CCR5). The inductions of these factors were associated with the inhibition of HIV replication in macrophages stimulated by 5'ppp-dsRNA. These observations highlight the importance of RIG-I signaling in macrophage innate immunity against HIV, which can be beneficial for the treatment of HIV disease, where intracellular immune defense is compromised by the virus.
Insights
RIG-I activation boosts innate immunity in macrophages, inhibiting HIV replication by inducing antiviral factors. This highlights RIG-I signaling
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- The RIG-I signaling pathway is crucial for type I interferon-dependent antiviral innate immunity.
- HIV infection compromises intracellular immune defense in macrophages.
Purpose of the Study:
- To investigate if RIG-I activation can inhibit HIV replication in macrophages.
- To understand the role of RIG-I signaling in macrophage antiviral defense against HIV.
Main Methods:
- Monocyte-derived macrophages were stimulated with 5'ppp-dsRNA, a synthetic RIG-I ligand.
- Expression of RIG-I, interferons (IFNs), interferon regulatory factors (IRFs), and HIV-restriction factors was analyzed.
- HIV replication levels were measured in stimulated and unstimulated macrophages.
Main Results:
- 5'ppp-dsRNA stimulation induced RIG-I, IFN-α/β, and IRFs in macrophages.
- RIG-I activation upregulated intracellular HIV-restriction factors, including ISGs, APOBEC3 family members, tetherin, and CC chemokines.
- Induced restriction factors correlated with significant inhibition of HIV replication.
Conclusions:
- RIG-I signaling plays a vital role in macrophage innate immunity against HIV.
- Targeting RIG-I activation may offer a therapeutic strategy for HIV disease by enhancing intracellular antiviral defense.
More Related Videos
12:43Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Experimental RNAi
Retrovirus Life Cycles
Size and Structure of Viral Genomes
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...